Bexarotene combined with lapatinib for the treatment of Cushing’s disease: evidence based on drug repositioning and experimental confirmation

Bexarotene combined with lapatinib for the treatment of Cushing’s disease: evidence based on drug repositioning and experimental confirmation
复制标题

贝沙罗汀联合拉帕替尼治疗库欣病:基于药物重新定位和实验证实的证据

DOI:
10.1038/s41392-020-00284-7
复制
发表时间:
2020-08
影响因子:
39.3
通讯作者:
Guanhua Du
Guanhua Du
中科院分区:
医学1区
文献类型:
--
作者:
Haoying Yu;Shuyue Ren;Jingrong Wang;Tingting Lv;Lan Sun;Guanhua Du

文献摘要

参考文献

相似文献

尊敬的编辑,库欣病(CD)是一种罕见的疾病,表现为库欣综合征,由促肾上腺皮质激素腺瘤持续过度分泌促肾上腺皮质激素(ACTH),随后刺激肾上腺分泌而引起。
Dear Editor, Cushing’s disease (CD) is a rare disease manifested as Cushing’s syndrome caused by adrenocorticotropic hormone (ACTH) consistently over-secreted by adrenocorticotropic adenomas, followed by stimulation of the adrenal gland to secrete conside
DOI: 10.1172/jci11098
发表时间: 2001-10
期刊: The Journal of clinical investigation
影响因子: --
作者:
M. Páez-Pereda;Damián Kovalovsky;Ursula Hopfner;M. Theodoropoulou;U. Pagotto;Eberhard Uhl;Marco Losa-M
通讯作者: M. Páez-Pereda;Damián Kovalovsky;Ursula Hopfner;M. Theodoropoulou;U. Pagotto;Eberhard Uhl;Marco Losa-M
DOI: 10.1210/jcem.81.7.8675592
发表时间: 1996-07
期刊: The Journal of clinical endocrinology and metabolism
影响因子: --
作者:
N. Sonino;Maria Zielezny;G. A. Fava;Francesco Fallo;Marco Boscaro
通讯作者: N. Sonino;Maria Zielezny;G. A. Fava;Francesco Fallo;Marco Boscaro
DOI: 10.3171/2014.10.focus14700
发表时间: 2015-02-01
影响因子: 4.1
作者:
Lau, Darryl;Rutledge, Caleb;Aghi, Manish K.
通讯作者: Aghi, Manish K.
DOI: 10.1507/endocrj.ej14-0115
发表时间: 2014
期刊: Endocrine journal
影响因子: 2
作者:
A. Uruno;Akiko Saito-hakoda;A. Yokoyama;N. Kogure;K. Matsuda;R. Parvin;K. Shimizu;I. Sato;M. Kudo;T. Yoshikawa;H. Kagechika;Y. Iwasaki;S. Ito;A. Sugawara
通讯作者: A. Uruno;Akiko Saito-hakoda;A. Yokoyama;N. Kogure;K. Matsuda;R. Parvin;K. Shimizu;I. Sato;M. Kudo;T. Yoshikawa;H. Kagechika;Y. Iwasaki;S. Ito;A. Sugawara
DOI: 10.1210/jc.81.7.2647
发表时间: 1996-07-01
影响因子: 5.8
作者:
Sonino, N;Zielezny, M;Boscaro, M
通讯作者: Boscaro, M